材料科学
巨噬细胞极化
自愈水凝胶
免疫系统
促炎细胞因子
基质金属蛋白酶
肿瘤微环境
细胞生物学
巨噬细胞
生物物理学
生物医学工程
癌症研究
免疫学
体外
炎症
医学
生物
内科学
生物化学
高分子化学
作者
Wei Chen,Changyong Wang,Wei Liu,Bicheng Zhao,Zhicheng Zeng,Fen Long,Chunlan Wang,Siwei Li,Naibo Lin,Jin Zhou
标识
DOI:10.1002/adma.202209041
摘要
Injectable hydrogels carrying therapeutic factors to modulate the infarct immune microenvironment show great potential in the treatment of myocardial infarction (MI). However, conventional injectable hydrogels release therapeutic factors in an uncontrolled manner, which leads to poor treatment efficacy and acute side effects on normal tissues. In this work, a matrix metalloproteinase (MMP)2/9-responsive hydrogel system (MPGC4) is developed, considering the characteristics of the post-MI microenvironment. MPGC4 consists of tetra-poly(ethylene glycol) (PEG) hydrogels and a composite gene nanocarrier (CTL4) that is composed of carbon dots (CDots) coupled with interleukin-4 plasmid DNA via electrostatic interactions. MPGC4 can be automatically triggered to release CTL4 on demand after MI to regulate the infarct immune microenvironment. In addition, due to the photoluminescence properties of CDots, a large amount of viscoelastic MPGC4 is found to be retained in situ after injection into the infarct region without leakage. The in vitro results demonstrate that CTL4 promotes proinflammatory M1 macrophage polarization to the anti-inflammatory M2 subtype and contributes to cardiomyocyte survival through macrophage transition. In a rat model of MI, MPGC4 clears MMPs and precisely targets CTL4 to the infarcted region. In particular, MPGC4 improves cardiac function by modulating macrophage transition to reduce early inflammatory responses and proangiogenic activity.
科研通智能强力驱动
Strongly Powered by AbleSci AI